Nicole J. Macarchuk serves as Angel Island Capital Management’s Managing Director and Chief Operating Officer and General Counsel. Prior to joining Angel Island Capital Management, Ms. Macarchuk was a Managing Director and General Counsel of Public Markets of Kohlberg Kravis Roberts & Co., including KKR Credit Advisors (US) LLC and KKR Financial Holdings LLC . Prior to joining KKR, Ms. Macarchuk was Co-General Counsel of Och-Ziff Capital Management Group LLC, responsible for the firm’s global private equity, energy, and transactional business groups and initiatives, as well as the U.S. public distressed debt, structured products, and public equity business units with respect to transactional matters. Prior to joining Och-Ziff, Ms. Macarchuk was counsel at O’Melveny & Myers LLP and O’Sullivan LLP focusing on private equity transactions and fund formation and an associate at White & Case focusing on banking and corporate credit transactions. Ms. Macarchuk received a B.A. in Economics from Fordham University and a J.D., cum laude, from Fordham University Law School.

Sarah has an extensive background in both finance and operations, working primarily in the healthcare space for the last 15 years. As an investment banker and private equity investor, she began to focus on investments in the healthcare space. After business school, she made the transition into healthcare operations, initially working for Tenet Healthcare. She completed a training program in hospital operations and was then asked to support major corporate initiatives in operations improvement and executive compensation. She then focused on honing her management skills, working as VP of Operations at St Elizabeths hospital for several years. Most recently, Sarah has focused on raising her young family while doing consulting assignments in the healthcare and non-profit sectors and running a small farm. Sarah received her Bachelors in Business Administration from the College of William & Mary and an MBA from Harvard Business School.

Von Nguyen is the Senior Vice President and Chief Medical Officer at Blue Cross Blue Shield of North Carolina where he develops new collaborations with providers in support of value-based care. Prior to joining BCBS North Carolina, he held senior roles at the Centers for Disease Control and Prevention and the Center for Medicare and Medicaid Innovation focused on driving improvement in population health. He has experience as a management consultant, medical underwriter, and medical director for Doctors Without Borders. Von is also a primary care provider and received his Medical Doctorate and Master of Public Health from the University of Texas. He trained at New York-Presbyterian Hospital and served as an Epidemic Intelligence Service Officer with the CDC.

Vivian Vasallo is a mission-driven leader with executive experience in Fortune 500, philanthropic and non-profit organizations. Vivian serves as Executive Director of Delta Dental Institute. Previously she held leadership positions at AARP Foundation, First American Financial Corporation and Milken Institute. She has led high-performing teams and has a demonstrated track record in business development, strategic planning and launching national initiatives. Her subject matter expertise is in financial services, housing, health and longevity. Vivian is working on a Masters of Science in Aging and Health at Georgetown University and holds a BA in International Relations from American University and MA in International Studies from University of Miami.

Georgia Casciato is passionate about contribution/collaboration amongst key stakeholders in the healthcare dialogue. She is the twice-elected President of Chicago Health Executives Forum, the largest chapter of the American College of Healthcare Executives (ACHE), and participates on numerous healthcare boards. Her expertise is in healthcare strategy, business development& growth, strategic partnerships, and entrepreneurship. Half of her career was invested in leadership roles with health systems/consultancies (Adventist, Aon, William Mercer, Inc., Columbia/HCA,) the other half in her own consultancy. Georgia is a requested speaker/moderator and has authored more than 30 articles including white papers for Modern Healthcare and Best Doctors. She has a longstanding background in wellness and community health outreach for underserved populations. Georgia is board certified in healthcare management and an ACHE fellow.

Dr. De Santi is a neuroscientist with almost 20 years of research experience and clinical expertise in Alzheimer’s disease. Currently, she holds the position as Executive Director, Global Medical Affairs, Patient Journey, Neurology Business Group, Eisai, Inc.

Prior to joining Eisai, Inc., she worked as VP, Medical Affairs North America & Asia Pacific for Life Molecular Imaging and Piramal Pharma, Global Medical Director for GE Healthcare, Global Clinical Director for Bayer Healthcare Pharmaceuticals, Inc. and briefly as Director of Research at the MedAvante, Research Institute.

In addition, she worked in academic settings, including as Associate Professor in the Department of Psychiatry at New York University Langone Medical Center, New York City.

Susan served as the Administrative Director at the Center for Brain Health and continues to hold an adjunct Associate Professorship at this institution. Dr. De Santi’s research focused on early diagnostic markers of mild cognitive impairment and Alzheimer’s disease using brain imaging, biological markers, and cognition. She was part of the team that identified, using both MRI and FDG PET, the brain regions showing the earliest changes in Alzheimer’s disease.

In addition, Dr. De Santi developed robust cognitive norms and robust imaging norms for identifying the earliest changes in healthy individuals which predict cognitive decline. Dr. De Santi received her Ph.D. focusing in neurolinguistics from the Department of Speech and Hearing Sciences at the Graduate School and University Center of the City University of New York. Dr. De Santi and the NYU Center for Brain Health are internationally recognized for their contribution to the early diagnosis of Alzheimer’s disease using a multi-modality approach. She has authored numerous scientific articles and has presented her work internationally.

Carladenise Edwards serves as Henry Ford Health System’s senior vice president and chief strategy officer. She previously served as the executive vice-president and chief strategy officer for Providence St. Joseph Health. She is an expert in health policy, public and private health services, managed care programs, and health information technology.

Prior to joining PSJH, Dr. Edwards served as the chief strategy officer for Alameda Health System in California, as well as the president and chief executive officer of Cal eConnect, a non-profit public benefit corporation created to serve as the state governance entity for electronic Health Information Exchange in California. She owns a successful consulting practice that provides strategy and business development services to health care provider groups, health plans, technology companies, community-based organizations, and state and federal government agencies. She holds a Master of Science degree in education from the University of Pennsylvania and a Doctorate in philosophy from the University of Florida.

Scott Filer brings nearly three decades of executive leadership experience in clinical research, public health and early-stage HealthTech companies. From life sciences to ambulatory care – and from nonprofit as well as governmental global health/pandemic preparedness organizations, to for-profit healthcare technology startups, Scott has served a wide array of organizations, including Force Diagnostics, Northwestern Memorial Hospital, Argonne National Laboratory, and the British Embassy in Washington DC. He has also served as adjunct faculty at the University of Chicago, on the board of advisors of the Benedictine University Goodwin School of Business, as a mentor on behalf of the mHUB HardTech Incubator in Chicago and as an editor of the DePaul University Journal of Healthcare Law. He presently serves as CEO of ProMedix, Inc. – a medical device startup dedicated to improving sepsis diagnosis and monitoring in hospitals and homecare settings; with offices at the Oregon Biosciences Incubator in Portland, OR, and at MATTER; a healthcare startup accelerator in Chicago, IL. Scott received his MPH from the Johns Hopkins University, Bloomberg School of Public Health and his MBA from the University of Notre Dame, Mendoza College of Business.

Jean C. O’Connor has spent nearly 20 years working at the intersection of law, policy, and public health. Jean is passionate about improving health outcomes through evidence-based interventions and policies, and building the public health workforce. She has worked in state health departments, the Centers for Disease Control and Prevention, and non-profit organizations. She teaches health professional students at Emory University and the University of Georgia part-time. She earned her joint JD and MPH from Emory University and her DrPH from the University of North Carolina at Chapel Hill. She is a member of the State Bar of Georgia and a Fellow in the American College of Healthcare Executives.

Santosh is Co-founder of Visgenx, Inc. a startup developing treatments for age-related macular degeneration which is the leading cause of vision loss worldwide and affects over 196 million individuals worldwide. Throughout his career, he has pursued a passion for developing drugs for addressing unmet medical needs in diverse areas ranging from cardiovascular disease, infectious disease, hemophilia, sickle cell disease and pediatric epilepsy. He has previously served as Chief Medical Officer for multiple public companies. In the area of community service, Santosh has provided pro bono clinical care at an indigent medical clinic and has served as an adjunct faculty member at the University of Medicine and Dentistry of New Jersey. He received his PhD from the Virginia Commonwealth University, his MD from the University of Maryland and his MBA from the Sloan School of Management at the Massachusetts Institute of Technology.

Edward Yip serves as Vice President, Legal Affairs, at Novavax, Inc. Previously, he held senior positions (including chief legal officer and chief compliance officer) at other life sciences companies, including QIAGEN, Celera Genomics, Evidera, Human Genome Sciences, ImClone Systems and Osiris Therapeutics.

Edward’s other community leadership roles include serving as a member of the National Diversity Advisory Council for the American Red Cross, audit chair for Heluna Health, commissioner on the Maryland Governor’s Commission on Asian Pacific American Affairs, co-chair of Maryland’s Asian American Business Conference, board chair for the Union of Pan Asian Communities and board member for Girl Scouts San Diego.